收费类受体:状细胞癌进展中的关键参与者
Jolanta Smok-Kalwat1, Paulina Mertowska2, Sebastian Mertowski2
1Department of Clinical Oncology, Holy Cross Cancer Centre, 3 Artwińskiego Street, 25-734 Kielce, Poland.
Journal of clinical medicine
|August 10, 2024
概括
淋巴细胞上的托尔类受体 (TLR) 水平在肺状细胞癌 (SCC) 患者和健康人群之间有所不同. 在SCC患者中,较高的TLR表达与晚期疾病和减少的存活率相关,这表明它在瘤进展中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 肺状细胞癌 (SCC) 是一种主要的肺癌亚型,具有不同的分子驱动因素和结果.
- 收费类受体 (TLRs) 是关键的免疫传感器,与癌症发展有关.
- 了解SCC中的TLR表达对于识别疾病机制和治疗点至关重要.
研究的目的:
- 为了比较新诊断的肺状细胞癌 (SCC) 患者与健康对照者的外周血液淋巴细胞上的托尔类受体 (TLR) 表达水平.
- 在三年内调查TLR表达,疾病阶段和患者存活率之间的关联.
- 探索TLRs在肺SCC的发展和进展中的潜在作用.
主要方法:
- 流细胞计用于测量TLR-2,TLR-3,TLR-4,TLR-7,TLR-8和TLR-9在周围血液淋巴细胞上的表达.
- 与酶相关的免疫吸收试验 (ELISA) 量化了研究的TLRs的可溶性形式.
- 对三年招聘期间收集的数据进行了统计分析.
主要成果:
- 在SCC患者和健康对照者之间观察到TLR表达的统计学上显著差异.
- 在SCC患者中,TLR水平升高与晚期疾病阶段有关.
- 在三年随访期间,较高的TLR表达与较差的患者存活率相关.
结论:
- 放松TLR水平的调节可能有助于肺SCC的发展,并影响瘤微环境.
- TLRs显示出作为肺SCC疾病进展和患者预后的生物标志物的潜力.
- 对TLRs作为治疗点的进一步研究可能会提高SCC治疗疗效和患者的治疗结果.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


